SYMBOLLON CORP
SC 13G/A, 1999-12-07
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: NAVARRE CORP /MN/, 10-Q/A, 1999-12-07
Next: ATLANTIC PREMIUM BRANDS LTD, 8-K, 1999-12-07






                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                  SCHEDULE 13G

                                 (Rule 13d-102)
             INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2
                    UNDER THE SECURITIES EXCHANGE ACT OF 1934
                               (Amendment No. 2)*

                              SYMBOLLON CORPORATION
- --------------------------------------------------------------------------------
                                (Name of Issuer)

                                  Common Stock
- --------------------------------------------------------------------------------
                         (Title of Class of Securities)

                                    87151H106
- --------------------------------------------------------------------------------
                                 (CUSIP Number)

                                October 22, 1999
- --------------------------------------------------------------------------------
             (Date of Event Which Requires Filing of This Statement)

Check the appropriate box to designate the Rule pursuant to which this Schedule
is field:

|_|      Rule 13d-1(b)
|X|      Rule 13d-(c)
|_|      Rule 13d-1(d)



<PAGE>
<TABLE>
<CAPTION>


                                                            SCHEDULE 13G
<S>                                                                           <C>
- -------------------------------------------------------                       ------------------------------------------------------
CUSIP No. 87151H106                                                                               Page 2 of 5 Pages
- -------------------------------------------------------                       ------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
1              NAME OF REPORTING PERSON
               S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
- ------------------------------------------------------------------------------------------------------------------------------------
               Richard M. Lilly - S.S. No. ###-##-####
2              CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*                                                              (a)|_|
                                                                                                                              (b)|_|
- ------------------------------------------------------------------------------------------------------------------------------------
3              SEC USE ONLY
- ------------------------------------------------------------------------------------------------------------------------------------
4              CITIZENSHIP OR PLACE OF ORGANIZATION

               United States
- ------------------------------------------------------------------------------------------------------------------------------------

          Number of              5            SOLE VOTING POWER                  214,847 shares
           Shares                6            SHARED VOTING POWER                73,263 shares
        Beneficially             7            SOLE DISPOSITIVE POWER             214,847 shares
          Owned by               8            SHARED DISPOSITIVE POWER           73,263 shares
            Each
          Reporting
           Person
            With
- ------------------------------------------------------------------------------------------------------------------------------------
9              AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

               288,110
- ------------------------------------------------------------------------------------------------------------------------------------
10             CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*                                                 |_|
- ------------------------------------------------------------------------------------------------------------------------------------
11             PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

               7.5%
- ------------------------------------------------------------------------------------------------------------------------------------
12             TYPE OF REPORTING PERSON*

               IN
- ------------------------------------------------------------------------------------------------------------------------------------
</TABLE>

                      *SEE INSTRUCTIONS BEFORE FILLING OUT!
          INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7



<PAGE>


CUSIP No. 87151H106                                            Page 3 of 5 Pages

                                   ATTACHMENT
                                   ----------

Item 1(a).        Name of Issuer

         Symbollon Corporation

Item 1(b).        Address of Issuer's Principal Executive Offices

         37 Loring Drive, Farmingham, MA 01702

Item 2(a).        Name of Person Filing

         Richard M. Lilly

Item 2(b).        Address of Principal Business Office or, if None, Residence

         11300 Sundance Lane, Boca Raton, Florida 33428

Item 2(c).        Citizenship

         See response to Number 4 on page 2.

Item 2(d).        Title of Class of Securities

         Class A Common Stock, par value $.001 per share

Item 2(e).        CUSIP No.

         87151H106

Item 3.           If This Statement Is Filed Pursuant to Rules 13d-1(b), or
                  13d-2(b), Check Whether the Person Filing Is a

                  (a)      [ ]    Broker or Dealer registered under Section 15
                           of the Act

                  (b)      [ ]    Bank as defined in section 3(a)(6) of the Act

                  (c)      [ ]    Insurance Company as defined in Section 3(a)
                           (19) of the Act

                  (d)      [ ]    Investment Company registered under Section 8
                           of the Investment Company Act

                  (e)      [ ]    Investment Adviser registered in accordance
                           with Rule 13d-1(b)(1)(ii)(e);



<PAGE>

CUSIP No. 87151H106                                            Page 4 of 5 Pages

                  (f)      [ ] Employee Benefit Plan, Pension fund which is
                           subject to the provisions of the Employee Retirement
                           Income Security Act of 1974 or Endowment Fund; see
                           Rule 13d-1(b)(1)(ii)(F)

                  (g)      [ ] Parent Holding Company, in accordance with Rule
                           13d-1(b)(ii)(G) (Note: See Item 7)

                  (h)      [ ] A savings association as defined in Section 3(b)
                           of the Federal Deposit Investment Act.

                  (i)      [ ] A church plan that is excluded from the
                           definition of an investment company under Section
                           3(c)(14) of the Investment Company Act;

                  (j)      [ ] Group, in accordance with Rule 13d-1(b)(1)(ii)
                           (j).

                  If this Statement is filed pursuant to Rule 13d-1(c), check
this box [X].

Item 4.           Ownership

         Provide the following information regarding the aggregate number and
percentage of the class of securities of the issuer identified in Item 1.

         (a)      Amount beneficially owned: Richard M. Lilly beneficially owns
                  288,110 shares of Class A Common Stock of the Issuer and
                  75,110 currently vested warrants to purchase Class A Common
                  Stock. 23,900 shares of Class A Common Stock are registered in
                  the name of Richard M. Lilly IRA, 25,000 shares of Class A
                  Common Stock are registered in the name of Richard and Tina M.
                  Lilly, 5,000 shares of Class A Common Stock are registered to
                  each of Mr. Lilly's sons, Nicholas S. Lilly and James M. Lilly
                  and 14,748 warrants are registered in the name of Indianapolis
                  Securities.

         (b)      Percent of class:
                           7.5%

         (c)      Number of shares as to which such person has:

         (i)      Sole power to vote or to direct the vote.   214,847 shares

         (ii)     Shared power to vote or to direct the vote. 73,263 shares.

         (iii)    Sole power to dispose or to direct the disposition of 214,847
shares.

         (iv)     Shared power to dispose or to direct the disposition of 73,263
shares.

Item 5.           Ownership of Five Percent or Less of a Class

         Not Applicable.


<PAGE>


CUSIP No. 87151H106                                            Page 5 of 5 Pages

Item 6.           Ownership of More Than Five Percent on Behalf of Another
                  Person

         None.

Item 7.           Identification and Classification of the Subsidiary Which
                  Acquired the Security Being Reported on by the Parent Holding
                  Company

         Not Applicable.

Item 8.           Identification and Classification of Members of the Group

         Not Applicable.

Item 9.           Notice of Dissolution of Group

         Not Applicable.

Item 10.          Certifications

         By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were not acquired and are not held for
the purpose of or with the effect of changing or influencing the control of the
issuer of the securities and were not acquired and are not held in connection
with or as a participant in any transaction having that purpose or effect.


                                    SIGNATURE


         After reasonable inquiry and to the best of the undersigned's knowledge
and belief, the undersigned certifies that the information set forth in this
statement is true, complete and correct.

Date: December 7, 1999

                                             /s/ Richard M. Lilly
                                             --------------------
                                                 Richard M. Lilly




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission